Satoshi Nagase
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Satoshi Nagase has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Tohru Ohe
Department of Cardiology, Sakakibara Heart Institute of Okayama
13 shared publicationsHiroshi Morita
Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
11 shared publications- Kazufumi Nakamura
Department of Cardiovascular Medicine, Shimane University Faculty of Medicine, Izumo, Japan
11 shared publications - Kengo Kusano
Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center Osaka Japan
11 shared publications - Nobuhiro Nishii
Department of Cardiovascular Therapeutics Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan
8 shared publications Hiroshi Ito
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
6 shared publications
Latest Publications
- 8 March 2017
- Published by Springer Nature in Heart and Vessels
- Vol. 32 (8) , 984-996
“Window Sliding” analysis combined with high-density and rapid electroanatomical mapping: its efficacy and the outcome of catheter ablation of atrial tachycardia
- 8 March 2017
- Published by Springer Nature in Heart and Vessels
- Vol. 32 (8) , 984-996
“Window Sliding” analysis combined with high-density and rapid electroanatomical mapping: its efficacy and the outcome of catheter ablation of atrial tachycardia
- 1 January 2015
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 79 (12) , 2568-2575
Incidence and Clinical Significance of Brugada Syndrome Masked by Complete Right Bundle-Branch Block
Background:Brugada syndrome (BrS)-type electrocardiogram (ECG) is concealed by complete right bundle-branch block (CRBBB) in some cases of BrS. Clinical significance of BrS masked by CRBBB is not well known.Methods and Results:We reviewed an ECG database of 326 BrS patients who had type 1 ECG with or without pilsicainide. “BrS masked by CRBBB” was defined on ECG as Conclusions:In a small BrS population, CRBBB can completely mask typical BrS-type ECG. BrS masked by CRBBB is associated with the same risk of fatal ventricular tachyarrhythmia as other BrS. (Circ J 2015; 79: 2568–2575)
- 1 January 2015
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 79 (12) , 2568-2575
Incidence and Clinical Significance of Brugada Syndrome Masked by Complete Right Bundle-Branch Block
Background:Brugada syndrome (BrS)-type electrocardiogram (ECG) is concealed by complete right bundle-branch block (CRBBB) in some cases of BrS. Clinical significance of BrS masked by CRBBB is not well known.Methods and Results:We reviewed an ECG database of 326 BrS patients who had type 1 ECG with or without pilsicainide. “BrS masked by CRBBB” was defined on ECG as Conclusions:In a small BrS population, CRBBB can completely mask typical BrS-type ECG. BrS masked by CRBBB is associated with the same risk of fatal ventricular tachyarrhythmia as other BrS. (Circ J 2015; 79: 2568–2575)
- Open Access
- 1 September 2014
- Published by Elsevier in Journal of Cardiology
- Vol. 64 (3) , 162-163
Association of early repolarization with long-term mortality and major adverse cardiac events in patients with ST-segment elevation myocardial infarction
- 1 September 2014
- Published by Elsevier in Journal of Cardiology
- Vol. 64 (3) , 162-163
Open AccessAssociation of early repolarization with long-term mortality and major adverse cardiac events in patients with ST-segment elevation myocardial infarction
- 1 February 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (2) , 314-317
Left ventricular epicardial electrogram recordings in idiopathic ventricular fibrillation with inferior and lateral early repolarization
- 1 February 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (2) , 314-317
Left ventricular epicardial electrogram recordings in idiopathic ventricular fibrillation with inferior and lateral early repolarization
- Open Access
- 1 January 2014
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 53 (7) , 725-728
Multiform Premature Ventricular Contractions and Polymorphic Ventricular Tachycardia Caused by Purkinje Activity with Slow Conduction in Idiopathic Ventricular Fibrillation
In several cases with idiopathic ventricular fibrillation (VF), VF was initiated by premature ventricular contractions (PVCs) from the Purkinje system. However, the precise characteristics of the Purkinje activity in patients with idiopathic VF remain unclear. We performed an electrophysiological study in a patient with idiopathic VF and examined the correlation between the Purkinje potential and the incidence of PVCs/polymorphic ventricular tachycardia (PMVT). In this case of idiopathic VF, the Purkinje activity caused multiform PVCs and PMVT. The The Purkinje activity and slow conduction of Purkinje fibers are associated with the occurrence of multiform PVCs and PMVT.
- 1 January 2014
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 53 (7) , 725-728
Open AccessMultiform Premature Ventricular Contractions and Polymorphic Ventricular Tachycardia Caused by Purkinje Activity with Slow Conduction in Idiopathic Ventricular Fibrillation
In several cases with idiopathic ventricular fibrillation (VF), VF was initiated by premature ventricular contractions (PVCs) from the Purkinje system. However, the precise characteristics of the Purkinje activity in patients with idiopathic VF remain unclear. We performed an electrophysiological study in a patient with idiopathic VF and examined the correlation between the Purkinje potential and the incidence of PVCs/polymorphic ventricular tachycardia (PMVT). In this case of idiopathic VF, the Purkinje activity caused multiform PVCs and PMVT. The The Purkinje activity and slow conduction of Purkinje fibers are associated with the occurrence of multiform PVCs and PMVT.
- Open Access
- 27 April 2012
- Published by Wiley in Journal of Arrhythmia
- Vol. 28 (3) , 196-201
Catheter ablation of three macroreentrant atrial tachycardias after surgical repair of Double‐Outlet Right Ventricle
- 27 April 2012
- Published by Wiley in Journal of Arrhythmia
- Vol. 28 (3) , 196-201
Open AccessCatheter ablation of three macroreentrant atrial tachycardias after surgical repair of Double‐Outlet Right Ventricle
- Open Access
- 31 May 2011
- Published by MDPI AG in Pharmaceuticals
- Vol. 4 (6) , 794-803
Use of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure
Background: Both nifekalant hydrochloride (NIF), a selective IKr blocker, and intravenous amiodarone (AMD), a multi-channel (including IKr blocking) blocker, have been reported to be efficacious for refractory arrhythmias. However, the optimal use of those antiarrhythmic drugs for refractory arrhythmia with severe heart failure has not been established. Intravenous AMD might be effective for arrhythmias refractory to NIF in patients with severe heart failure. Here, we report that intravenous amiodarone was effective in the treatment of nifekalant-resistant in a group of arrhythmia patients with severe heart failure. Methods: Eleven severe heart failure patients who had received intravenous AMD for treatment of NIF-resistant arrhythmias were included in this study, and retrospective analysis was performed. Clinical efficacy (terminative and preventive effects on arrhythmia) of intravenous AMD was evaluated. Results: All cases were emergent cases and had depressed left ventricular ejection fraction (30 ± 13%). Clinical arrhythmias were ventricular fibrillation (VF) in four patients, ventricular tachycardia (VT) in six patients, and atrial fibrillation (AF) in one patient. NIF was administered to all patients by intravenous injection. After administration of NIF, VT/VF/AF was terminated in seven of the 10 patients, but a preventive effect was not obtained in any of the patients (NIF-resistance). Intravenous AMD (maintenance dose: 484 ± 166 mg/day) was effective both in termination (80%) and in prevention (80%) of VT/VF events in those patients. It was also effective in termination (80%) and prevention (60%) of AF events refractory to NIF. During continuous AMD administration, no significant adverse effects or proarrhythmic effects were observed in any of the patients. Five patients died within one month, but there was no arrhythmic deaths. Conclusions: Intravenous AMD was effective in NIF-resistant lethal arrhythmias and was relatively safe in emergent cases with severe heart failure.
- 31 May 2011
- Published by MDPI AG in Pharmaceuticals
- Vol. 4 (6) , 794-803
Open AccessUse of Intravenous Amiodarone in the Treatment of Nifekalant-Resistant Arrhythmia: A Review of 11 Consecutive Cases with Severe Heart Failure
Background: Both nifekalant hydrochloride (NIF), a selective IKr blocker, and intravenous amiodarone (AMD), a multi-channel (including IKr blocking) blocker, have been reported to be efficacious for refractory arrhythmias. However, the optimal use of those antiarrhythmic drugs for refractory arrhythmia with severe heart failure has not been established. Intravenous AMD might be effective for arrhythmias refractory to NIF in patients with severe heart failure. Here, we report that intravenous amiodarone was effective in the treatment of nifekalant-resistant in a group of arrhythmia patients with severe heart failure. Methods: Eleven severe heart failure patients who had received intravenous AMD for treatment of NIF-resistant arrhythmias were included in this study, and retrospective analysis was performed. Clinical efficacy (terminative and preventive effects on arrhythmia) of intravenous AMD was evaluated. Results: All cases were emergent cases and had depressed left ventricular ejection fraction (30 ± 13%). Clinical arrhythmias were ventricular fibrillation (VF) in four patients, ventricular tachycardia (VT) in six patients, and atrial fibrillation (AF) in one patient. NIF was administered to all patients by intravenous injection. After administration of NIF, VT/VF/AF was terminated in seven of the 10 patients, but a preventive effect was not obtained in any of the patients (NIF-resistance). Intravenous AMD (maintenance dose: 484 ± 166 mg/day) was effective both in termination (80%) and in prevention (80%) of VT/VF events in those patients. It was also effective in termination (80%) and prevention (60%) of AF events refractory to NIF. During continuous AMD administration, no significant adverse effects or proarrhythmic effects were observed in any of the patients. Five patients died within one month, but there was no arrhythmic deaths. Conclusions: Intravenous AMD was effective in NIF-resistant lethal arrhythmias and was relatively safe in emergent cases with severe heart failure.
- 1 January 2011
- Published by Wiley in Journal of Arrhythmia
- Vol. 27 (Supplement) , OP36_4
Pronounced Late Potential at Night Time, Bradycardia, and Pronounced Vagal Activity May Be a Risk Marker of Ventricular Fibrillation in Brugada Syndrome
- 1 January 2011
- Published by Wiley in Journal of Arrhythmia
- Vol. 27 (Supplement) , OP36_4
Pronounced Late Potential at Night Time, Bradycardia, and Pronounced Vagal Activity May Be a Risk Marker of Ventricular Fibrillation in Brugada Syndrome
- 1 January 2011
- Published by Wiley in Journal of Arrhythmia
- Vol. 27 (Supplement) , CP1_07
Impact of Infero/Lateral Early Repolarization Pattern in Patients with Brugada Syndrome
- 1 January 2011
- Published by Wiley in Journal of Arrhythmia
- Vol. 27 (Supplement) , CP1_07
Impact of Infero/Lateral Early Repolarization Pattern in Patients with Brugada Syndrome
- 30 September 2008
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 14 (7) , S174
Increased Cardiomyocyte Stiffness of the Transverse Direction in the Rat Heart Induced by Chronic Beta-Adrenergic Stimulation
- 30 September 2008
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 14 (7) , S174
Increased Cardiomyocyte Stiffness of the Transverse Direction in the Rat Heart Induced by Chronic Beta-Adrenergic Stimulation